Trials / Completed
CompletedNCT03313635
Evaluation of Prealbumin Levels in Men With Low-T
Prealbumin (Transthyretin) Levels in Men With Low-T
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 19 (actual)
- Sponsor
- Beckman Coulter, Inc. · Industry
- Sex
- Male
- Age
- 40 Years – 75 Years
- Healthy volunteers
- —
Summary
This is a single-center study intended to evaluate prealbumin (transthyretin), a marker of anabolic metabolism, in men with androgen deficiency (Low-T). There is emerging evidence that prealbumin is an indicator of anabolic, versus catabolic, metabolism, and that lower levels may be associated with hypogonadism.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Men presenting with low-T | Evaluation of prealbumin levels. |
Timeline
- Start date
- 2017-09-08
- Primary completion
- 2017-12-31
- Completion
- 2017-12-31
- First posted
- 2017-10-18
- Last updated
- 2018-07-13
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03313635. Inclusion in this directory is not an endorsement.